Eliglustat hemitartrate

CAS: 928659-70-5

Ref. 3D-DMB65970

Produktinformation

• Name: Eliglustat hemitartrate
• Synonyme: Octanamide, N-[(1R,2R)-2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (2:1), Eliglustat tartrate, Genz 112638

Beschreibung

Eliglustat hemitartrate is a drug that inhibits the enzyme glucosylceramide synthase, which is involved in the production of glucosylceramide. Eliglustat hemitartrate is used to treat Gaucher disease, a rare genetic disorder where fatty substances accumulate in the liver and spleen. Eliglustat hemitartrate has been shown to reduce the levels of glucosylceramide in patients with Gaucher disease and may be an effective treatment for this condition. It also has been shown to inhibit P-glycoprotein (P-gp), which may allow more eliglustat to enter cells.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 959.17 g/mol
• Formel: C₅₀H₇₈N₄O₁₄
• Reinheit: Min. 98 Area-%
• Farbe/Form: Powder